Latest filing published 20 Dec 2022 for Synaptogenix, Inc., €22k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Daniel L. Alkon, listed as senior executive, appears in our data through filings on TAO Synergies Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 14 June 2021 and the latest from 16 December 2022.
In open-market terms, that means 1 purchase worth €68k on one side and 1 sale worth €22k on the other. The net balance comes to €46k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants. Since January 2022: no purchases and 1 sale on the market.
The latest filing, published on 20 December 2022, reports an open-market sale of €22k in TAO Synergies Inc. The last purchase on record was published on 16 June 2021, which is 1,951 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations